Carborane-based carbonic anhydrase inhibitors.
Brynda, J., Mader, P., Sicha, V., Fabry, M., Poncova, K., Bakardiev, M., Gruner, B., Cigler, P., Rezacova, P.(2013) Angew Chem Int Ed Engl 52: 13760-13763
- PubMed: 24307504 
- DOI: https://doi.org/10.1002/anie.201307583
- Primary Citation of Related Structures:  
4MDG, 4MDL, 4MDM - PubMed Abstract: 
CA inhibitors: Human carbonic anhydrases (CAs) are diagnostic and therapeutic targets. Various carborane cages are shown to act as active-site-directed inhibitors, and substitution with a sulfamide group and other substituents leads to compounds with high selectivity towards the cancer-specific isozyme IX. Crystal structures of the carboranes in the active site provide information that can be applied to the structure-based design of specific inhibitors.
Organizational Affiliation: 
Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, v.v.i. Vídeňská 1083, 142 20 Prague 4 (Czech Republic); Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i. Flemingovo nám. 2, 16610 Prague 6 (Czech Republic).